Software - Infrastructure
Compare Stocks
4 / 10Stock Comparison
RAMP vs CDLX vs MGNI vs IAS
Revenue, margins, valuation, and 5-year total return — side by side.
Advertising Agencies
Advertising Agencies
Advertising Agencies
RAMP vs CDLX vs MGNI vs IAS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Infrastructure | Advertising Agencies | Advertising Agencies | Advertising Agencies |
| Market Cap | $1.90B | $43M | $2.01B | $1.74B |
| Revenue (TTM) | $796M | $206M | $723M | $591M |
| Net Income (TTM) | $69M | $-95M | $159M | $47M |
| Gross Margin | 70.4% | 38.9% | 63.4% | 77.4% |
| Operating Margin | 7.1% | -22.8% | 14.8% | 11.1% |
| Forward P/E | 13.1x | — | 13.4x | 27.5x |
| Total Debt | $36M | $215M | $279M | $58M |
| Cash & Equiv. | $413M | $49M | $553M | $84M |
RAMP vs CDLX vs MGNI vs IAS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| LiveRamp Holdings, … (RAMP) | 100 | 64.4 | -35.6% |
| Cardlytics, Inc. (CDLX) | 100 | 0.6 | -99.4% |
| Magnite, Inc. (MGNI) | 100 | 41.4 | -58.6% |
| Integral Ad Science… (IAS) | 100 | 50.0 | -50.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RAMP vs CDLX vs MGNI vs IAS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RAMP carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 31.6% 10Y total return vs MGNI's -4.7%
- 13.0% revenue growth vs CDLX's -16.2%
- Lower P/E (13.1x vs 27.5x)
- 5.7% ROA vs CDLX's -31.5%, ROIC 0.7% vs -18.3%
CDLX lags the leaders in this set but could rank higher in a more targeted comparison.
MGNI is the clearest fit if your priority is quality.
- 22.0% margin vs CDLX's -46.0%
IAS is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- beta 0.83
- Rev growth 11.7%, EPS growth 413.4%, 3Y rev CAGR 17.9%
- Lower volatility, beta 0.83, Low D/E 5.7%, current ratio 3.02x
- Beta 0.83, current ratio 3.02x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.0% revenue growth vs CDLX's -16.2% | |
| Value | Lower P/E (13.1x vs 27.5x) | |
| Quality / Margins | 22.0% margin vs CDLX's -46.0% | |
| Stability / Safety | Beta 0.83 vs CDLX's 3.18 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +40.1% vs CDLX's -63.8% | |
| Efficiency (ROA) | 5.7% ROA vs CDLX's -31.5%, ROIC 0.7% vs -18.3% |
RAMP vs CDLX vs MGNI vs IAS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
RAMP vs CDLX vs MGNI vs IAS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IAS leads in 2 of 6 categories
RAMP leads 1 • CDLX leads 0 • MGNI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
IAS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
RAMP is the larger business by revenue, generating $796M annually — 3.9x CDLX's $206M. MGNI is the more profitable business, keeping 22.0% of every revenue dollar as net income compared to CDLX's -46.0%. On growth, IAS holds the edge at +15.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $796M | $206M | $723M | $591M |
| EBITDAEarnings before interest/tax | $71M | -$23M | $145M | $125M |
| Net IncomeAfter-tax profit | $69M | -$95M | $159M | $47M |
| Free Cash FlowCash after capex | $169M | $6M | $44M | $165M |
| Gross MarginGross profit ÷ Revenue | +70.4% | +38.9% | +63.4% | +77.4% |
| Operating MarginEBIT ÷ Revenue | +7.1% | -22.8% | +14.8% | +11.1% |
| Net MarginNet income ÷ Revenue | +8.6% | -46.0% | +22.0% | +7.9% |
| FCF MarginFCF ÷ Revenue | +21.3% | +2.9% | +6.1% | +27.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.6% | -44.6% | +5.5% | +15.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.6% | +3.8% | +142.9% | -57.4% |
Valuation Metrics
Evenly matched — RAMP and CDLX each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, MGNI trades at a 67% valuation discount to IAS's 45.0x P/E. On an enterprise value basis, MGNI's 11.4x EV/EBITDA is more attractive than RAMP's 67.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.9B | $43M | $2.0B | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $210M | $1.7B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -2491.74x | -0.40x | 14.74x | 44.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.14x | — | 13.45x | 27.54x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 67.50x | — | 11.43x | 13.74x |
| Price / SalesMarket cap ÷ Revenue | 2.55x | 0.18x | 2.81x | 3.27x |
| Price / BookPrice ÷ Book value/share | 2.14x | — | 2.33x | 1.70x |
| Price / FCFMarket cap ÷ FCF | 12.31x | 4.89x | 12.11x | 22.44x |
Profitability & Efficiency
Evenly matched — RAMP and MGNI each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
MGNI delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-9 for CDLX. RAMP carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to MGNI's 0.30x. On the Piotroski fundamental quality scale (0–9), CDLX scores 6/9 vs RAMP's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.1% | -8.7% | +18.6% | +4.2% |
| ROA (TTM)Return on assets | +5.7% | -31.5% | +5.3% | +3.9% |
| ROICReturn on invested capital | +0.7% | -18.3% | +9.5% | +4.6% |
| ROCEReturn on capital employed | +0.5% | -20.9% | +7.3% | +5.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.04x | — | 0.30x | 0.06x |
| Net DebtTotal debt minus cash | -$377M | $167M | -$275M | -$27M |
| Cash & Equiv.Liquid assets | $413M | $49M | $553M | $84M |
| Total DebtShort + long-term debt | $36M | $215M | $279M | $58M |
| Interest CoverageEBIT ÷ Interest expense | 31.98x | -14.37x | 4.03x | 93.78x |
Total Returns (Dividends Reinvested)
RAMP leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RAMP five years ago would be worth $6,085 today (with dividends reinvested), compared to $78 for CDLX. Over the past 12 months, IAS leads with a +40.1% total return vs CDLX's -63.8%. The 3-year compound annual growth rate (CAGR) favors MGNI at 16.7% vs CDLX's -48.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.0% | -30.2% | -12.8% | — |
| 1-Year ReturnPast 12 months | +11.8% | -63.8% | +12.6% | +40.1% |
| 3-Year ReturnCumulative with dividends | +26.8% | -86.5% | +58.7% | -39.0% |
| 5-Year ReturnCumulative with dividends | -39.2% | -99.2% | -60.9% | -49.8% |
| 10-Year ReturnCumulative with dividends | +31.6% | -94.2% | -4.7% | -49.8% |
| CAGR (3Y)Annualised 3-year return | +8.2% | -48.8% | +16.7% | -15.2% |
Risk & Volatility
IAS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IAS is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than CDLX's 3.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IAS currently trades 100.0% from its 52-week high vs CDLX's 23.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.97x | 3.18x | 1.63x | 0.83x |
| 52-Week HighHighest price in past year | $35.20 | $3.28 | $26.65 | $10.34 |
| 52-Week LowLowest price in past year | $21.71 | $0.66 | $10.82 | $7.29 |
| % of 52W HighCurrent price vs 52-week peak | +85.7% | +23.8% | +52.5% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 56.1 | 36.6 | 55.4 | 67.5 |
| Avg Volume (50D)Average daily shares traded | 651K | 1.2M | 2.1M | 0 |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: RAMP as "Buy", MGNI as "Buy", IAS as "Buy". Consensus price targets imply 45.9% upside for RAMP (target: $44) vs 28.6% for MGNI (target: $18).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Buy |
| Price TargetConsensus 12-month target | $44.00 | — | $18.00 | $14.29 |
| # AnalystsCovering analysts | 12 | — | 31 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.3% | 0.0% | +2.3% | 0.0% |
IAS leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). RAMP leads in 1 (Total Returns). 2 tied.
RAMP vs CDLX vs MGNI vs IAS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RAMP or CDLX or MGNI or IAS a better buy right now?
For growth investors, LiveRamp Holdings, Inc.
(RAMP) is the stronger pick with 13. 0% revenue growth year-over-year, versus -16. 2% for Cardlytics, Inc. (CDLX). Magnite, Inc. (MGNI) offers the better valuation at 14. 7x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate LiveRamp Holdings, Inc. (RAMP) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RAMP or CDLX or MGNI or IAS?
On trailing P/E, Magnite, Inc.
(MGNI) is the cheapest at 14. 7x versus Integral Ad Science Holding Corp. at 45. 0x. On forward P/E, LiveRamp Holdings, Inc. is actually cheaper at 13. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — RAMP or CDLX or MGNI or IAS?
Over the past 5 years, LiveRamp Holdings, Inc.
(RAMP) delivered a total return of -39. 2%, compared to -99. 2% for Cardlytics, Inc. (CDLX). Over 10 years, the gap is even starker: RAMP returned +31. 6% versus CDLX's -94. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RAMP or CDLX or MGNI or IAS?
By beta (market sensitivity over 5 years), Integral Ad Science Holding Corp.
(IAS) is the lower-risk stock at 0. 83β versus Cardlytics, Inc. 's 3. 18β — meaning CDLX is approximately 282% more volatile than IAS relative to the S&P 500. On balance sheet safety, LiveRamp Holdings, Inc. (RAMP) carries a lower debt/equity ratio of 4% versus 30% for Magnite, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RAMP or CDLX or MGNI or IAS?
By revenue growth (latest reported year), LiveRamp Holdings, Inc.
(RAMP) is pulling ahead at 13. 0% versus -16. 2% for Cardlytics, Inc. (CDLX). On earnings-per-share growth, the picture is similar: Magnite, Inc. grew EPS 493. 8% year-over-year, compared to -107. 1% for LiveRamp Holdings, Inc.. Over a 3-year CAGR, IAS leads at 17. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RAMP or CDLX or MGNI or IAS?
Magnite, Inc.
(MGNI) is the more profitable company, earning 20. 3% net margin versus -44. 4% for Cardlytics, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MGNI leads at 13. 7% versus -20. 2% for CDLX. At the gross margin level — before operating expenses — IAS leads at 78. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RAMP or CDLX or MGNI or IAS more undervalued right now?
On forward earnings alone, LiveRamp Holdings, Inc.
(RAMP) trades at 13. 1x forward P/E versus 27. 5x for Integral Ad Science Holding Corp. — 14. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RAMP: 45. 9% to $44. 00.
08Which pays a better dividend — RAMP or CDLX or MGNI or IAS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is RAMP or CDLX or MGNI or IAS better for a retirement portfolio?
For long-horizon retirement investors, Integral Ad Science Holding Corp.
(IAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 83)). Cardlytics, Inc. (CDLX) carries a higher beta of 3. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IAS: -49. 8%, CDLX: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RAMP and CDLX and MGNI and IAS?
These companies operate in different sectors (RAMP (Technology) and CDLX (Communication Services) and MGNI (Communication Services) and IAS (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RAMP is a small-cap quality compounder stock; CDLX is a small-cap quality compounder stock; MGNI is a small-cap deep-value stock; IAS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.